Drug intelligence / Profile preview

alpha-cyclodextrin

Development stage
Unknown
Lead developer
Wacker Chemie
Modality
Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
Administration
Oral, Intravenous, Topical, Ophthalmic
01

Overview

Alpha-cyclodextrin is a cyclic oligosaccharide composed of six α-(1→4) linked D-glucopyranose units. It is produced from starch by enzymatic conversion and belongs to the class of organic compounds known as oligosaccharides. Alpha-cyclodextrin acts primarily as a soluble dietary fiber with the ability to bind dietary fats in the gastrointestinal tract, thereby reducing their absorption. This mechanism can contribute to weight loss and improved metabolic parameters such as glucose metabolism and insulin sensitivity. It has also been investigated for its use as an excipient in pharmaceutical formulations to enhance drug solubility and bioavailability[1][2][3][4][5][6]. The compound is considered safe for human consumption with no significant side effects reported at recommended doses[6].

Brand names
ALFADEX
Other names
cyclohexa-amyloseα-cyclodextrin

Beyond the preview

Go deeper on alpha-cyclodextrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-cyclodextrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call